New York, United States
mend™, founded in 2018, stands as the leading force in the biotechnology sector with a specific focus on nutritional science research. As a life sciences and biotechnology company, their mission is unwavering: to aid in the healing process. They collaborate with top-tier hospitals and universities to create evidence-based clinical nutrition products that promise to enhance patient outcomes.
Their commitment has gained them the trust of prestigious clients, including US special forces and professional sports teams. Headquartered in the United States, mend™ is strategically positioned at the intersection of Biotechnology, Health Care, and Life Sciences industries.
The company recently received a $1.50M early VC investment as of 01 June 2025, reflecting strong investor confidence and optimism in their cutting-edge research and product development capabilities. This investment marks a significant milestone and positions mend™ for continued growth and impact in nutritional science.
